Medicis Global Services Corporation / Global Services Corporation / TERMS AE / Medicis Pharmaceutical Corporation / Q-Med AB / /
Country
United States / Iceland / Sweden / Finland / /
Event
FDA Phase / /
IndustryTerm
grade assessment tool / study product / /
MedicalCondition
xenogeneic disease / pain / /
MedicalTreatment
Lips Restylane / Restylane / /
Organization
INSTITUTIONAL REVIEW BOARD / US Food and Drug Administration / FDA / 18th World Medical Assembly / / /
Position
INVESTIGATOR / TREATING INVESTIGATOR GLOBAL AESTHETIC IMPROVEMENT SCALE / Principal Investigator / The Principal Investigator / designated representative / /
Product
Restylane / New Drug / MA-1300-15 / /
ProvinceOrState
Arizona / /
PublishedMedium
24 HOURS / /
Technology
5 217 Study Protocol / 5 218 Study Protocol / 5 222 Study Protocol / 5 216 Study Protocol / 5 220 Study Protocol / 5 223 Study Protocol / 5 215 Study Protocol / 5 221 Study Protocol / /
Appendix[removed]: Protocol and Protocol Amendments (MA[removed])